These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 14572305)

  • 1. Magnesium for the prevention and treatment of acute mountain sickness.
    Dumont L; Lysakowski C; Tramèr MR; Junod JD; Mardirosoff C; Tassonyi E; Kayser B
    Clin Sci (Lond); 2004 Mar; 106(3):269-77. PubMed ID: 14572305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of magnesium, high altitude and acute mountain sickness on blood flow velocity in the middle cerebral artery.
    Lysakowski C; Von Elm E; Dumont L; Junod JD; Tassonyi E; Kayser B; Tramèr MR
    Clin Sci (Lond); 2004 Mar; 106(3):279-85. PubMed ID: 14572304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial.
    Chow T; Browne V; Heileson HL; Wallace D; Anholm J; Green SM
    Arch Intern Med; 2005 Feb; 165(3):296-301. PubMed ID: 15710792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sumatriptan for prevention of acute mountain sickness: randomized clinical trial.
    Jafarian S; Gorouhi F; Salimi S; Lotfi J
    Ann Neurol; 2007 Sep; 62(3):273-7. PubMed ID: 17557349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose theophylline reduces symptoms of acute mountain sickness.
    Küpper TE; Strohl KP; Hoefer M; Gieseler U; Netzer CM; Netzer NC
    J Travel Med; 2008; 15(5):307-14. PubMed ID: 19006503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pressurization and acute mountain sickness.
    Kayser B; Jean D; Herry JP; Bärtsch P
    Aviat Space Environ Med; 1993 Oct; 64(10):928-31. PubMed ID: 8240197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginkgo biloba does--and does not--prevent acute mountain sickness.
    Leadbetter G; Keyes LE; Maakestad KM; Olson S; Tissot van Patot MC; Hackett PH
    Wilderness Environ Med; 2009; 20(1):66-71. PubMed ID: 19364166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent altitude exposures reduce acute mountain sickness at 4300 m.
    Beidleman BA; Muza SR; Fulco CS; Cymerman A; Ditzler D; Stulz D; Staab JE; Skrinar GS; Lewis SF; Sawka MN
    Clin Sci (Lond); 2004 Mar; 106(3):321-8. PubMed ID: 14561214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication for emergency department treatment of migraine headache.
    Corbo J; Esses D; Bijur PE; Iannaccone R; Gallagher EJ
    Ann Emerg Med; 2001 Dec; 38(6):621-7. PubMed ID: 11719739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cysteinyl leukotriene blockade does not prevent acute mountain sickness.
    Muza SR; Kaminsky D; Fulco CS; Banderet LE; Cymerman A
    Aviat Space Environ Med; 2004 May; 75(5):413-9. PubMed ID: 15152893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the Emergency Department.
    Cete Y; Dora B; Ertan C; Ozdemir C; Oktay C
    Cephalalgia; 2005 Mar; 25(3):199-204. PubMed ID: 15689195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of acute mountain sickness by different score protocols in the Swiss Alps.
    Maggiorini M; Müller A; Hofstetter D; Bärtsch P; Oelz O
    Aviat Space Environ Med; 1998 Dec; 69(12):1186-92. PubMed ID: 9856545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetazolamide plus low-dose dexamethasone is better than acetazolamide alone to ameliorate symptoms of acute mountain sickness.
    Bernhard WN; Schalick LM; Delaney PA; Bernhard TM; Barnas GM
    Aviat Space Environ Med; 1998 Sep; 69(9):883-6. PubMed ID: 9737760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginkgo biloba decreases acute mountain sickness in people ascending to high altitude at Ollagüe (3696 m) in northern Chile.
    Moraga FA; Flores A; Serra J; Esnaola C; Barriento C
    Wilderness Environ Med; 2007; 18(4):251-7. PubMed ID: 18076292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral antioxidant supplementation does not prevent acute mountain sickness: double blind, randomized placebo-controlled trial.
    Baillie JK; Thompson AA; Irving JB; Bates MG; Sutherland AI; Macnee W; Maxwell SR; Webb DJ
    QJM; 2009 May; 102(5):341-8. PubMed ID: 19273551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ibuprofen prevents altitude illness: a randomized controlled trial for prevention of altitude illness with nonsteroidal anti-inflammatories.
    Lipman GS; Kanaan NC; Holck PS; Constance BB; Gertsch JH;
    Ann Emerg Med; 2012 Jun; 59(6):484-90. PubMed ID: 22440488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT).
    Gertsch JH; Basnyat B; Johnson EW; Onopa J; Holck PS
    BMJ; 2004 Apr; 328(7443):797. PubMed ID: 15070635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spironolactone does not prevent acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial by SPACE Trial Group (spironolactone and acetazolamide trial in the prevention of acute mountain sickness group).
    Basnyat B; Holck PS; Pun M; Halverson S; Szawarski P; Gertsch J; Steif M; Powell S; Khanal S; Joshi A; Shankar R; Karambay J; Alexander HD; Stone A; Morrissey C; Thompson BH; Farrar J;
    Wilderness Environ Med; 2011 Mar; 22(1):15-22. PubMed ID: 21377114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous iron supplementation may protect against acute mountain sickness: a randomized, double-blinded, placebo-controlled trial.
    Talbot NP; Smith TG; Privat C; Nickol AH; Rivera-Ch M; León-Velarde F; Dorrington KL; Robbins PA
    High Alt Med Biol; 2011; 12(3):265-9. PubMed ID: 21962070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
    LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A
    Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.